ATTACHEMENT B SALIENT CHARACTERISTICS.docx
DOCX document 15 KB Posted
- Solicitation number
- 36C26223Q1496
About this file
This document outlines the salient characteristics required for COVID-19 test reagents and supplies to be used on a Panther Fusion system owned by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. The reagents, controls, calibration materials, disposables and consumable parts must be 100% compatible without modification for the Panther Fusion, FDA approved or have EUA, and include detection in under three hours. The SARS-CoV-2 assay must be authorized for both symptomatic and asymptomatic patients. The SARS-CoV-2/Flu A/B/RSV assay must include four tests in one, and quality control must only be required every 24 hours or with a new kit to reduce time and costs. Pricing must incorporate all applicable handling, shipping, and hazardous material fees. The related federal contract opportunity, solicitation number 36C26223Q1496, seeks COVID-19 test reagents and supplies for the Panther Fusion system that meet the outlined salient characteristics.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C26223Q1496.docx | DOCX document | |
| S02 - RFQ COVID-19 REAGENTS.docx | DOCX document | |
| Attachment A .xlsx | XLSX spreadsheet |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
ATTACHEMENT B - SALIENT CHARACTERISTICS
1. Must be compatible 100% compatible without modification for use on the current VA-owned Panther Fusion System.
2. Reagents, Controls, Calibration Materials, Disposables and Consumable Parts must be 100% compatible with all features, must physically fit without alteration, and not void the service and maintenance contract of the current VA-owned Panther Fusion System.
3. Reagents, Controls, Calibration Materials, Disposables and Consumable Parts must be FDA approved, or have EUA through the FDA.
4. Time of detection must be less than three (3) hours.
5. SARS-CoV-2 assay must be authorized to use on both symptomatic and asymptomatic patients.
6. SARS-CoV-2/Flu A/B/RSV assay must include four (4) tests in one (1) assay.
7. Quality Control (QC) must only be required every 24 hours, or with a new kit, to reduce time and costs.
8. Pricing must include all handling, HAZMAT, dry-ice and shipping fees as applicable.
File details come from the government source that posted it. Updated .